PAD Costs Economics - Press Releases

skip to content

PRESS RELEASES

According to THE SAGE GROUP the Total Annual Economic Burden of Peripheral Artery Disease (PAD) in the U.S. Exceeds $300 Billion. November 14, 2011.

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Economic Burden of the Disease. September 8, 2011.

THE SAGE GROUP Estimates That the 2010 Annual Economic Cost of Peripheral Artery Disease (PAD) Was $164 to $290 Billion. June 1, 2011.

THE SAGE GROUP Announces that Mary L. Yost, President, Will Make a Presentation on Peripheral Artery Disease (PAD) Prevalence and Economics at the New Cardiovascular Horizons Conference. May 10, 2011.

THE SAGE GROUP Highlights Specialized Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) Consulting Services. January 25, 2011

THE SAGE GROUP Reports that in 2010 Approximately 3 Million People in Western Europe Suffer from Critical Limb Ischemia. December 15, 2010

THE SAGE GROUP Reports that in 2010 Approximately 2.8 Million People in the United States Suffered from Critical Limb Ischemia. December 14, 2010

According to THE SAGE GROUP A Significant Number of Diabetic Foot Ulcer Patients Also Suffer from Peripheral Artery Disease (PAD). October 18, 2010

THE SAGE GROUP Releases New Estimates for the United States Prevalence of Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI). September 30, 2010.

THE SAGE GROUP Reports That in 2008 Almost 1 million Interventional Procedures Were Performed to Treat Peripheral Artery Disease. June 22, 2010.

According to THE SAGE GROUP, the National Bill for the Treatment of Peripheral Artery Disease (PAD) Exceeds $14 Billion. June 2, 2010.

THE SAGE GROUP Announces that Mary L. Yost, President, will Make a Presentation at the NEW CARDIOVASCULAR HORIZONS Conference. May 18, 2010.

According to THE SAGE GROUP, Almost 3 Million People in India Suffer From Critical Limb Ischemia Caused by Atherosclerotic Peripheral Arterial Disease. November 12, 2009.

THE SAGE GROUP Supports the "STOP P.A.D." Petition Drive to Expand Medicare Coverage to Test patients for peripheral Arterial Disease. September 15, 2009.

THE SAGE GROUP Reports that in 2007 Approximately 2.8 million people in Western Europe Suffered from Critical Limb Ischemia. October 20, 2008.

THE SAGE GROUP Reports that in 2007 Between 4 and 8.4 Million Europeans Suffered from the Symptoms of Intermittent Claudication. February 28, 2008.

THE SAGE GROUP Finds a Significant Number of New Pharmaceuticals in Clinical Trials for Treatment of Peripheral Arterial Disease. February 13, 2008.

THE SAGE GROUP Reports that in 2006 Approximately 2 Million People in the United States Suffered from Critical Limb Ischemia. April 17, 2007.

THE SAGE GROUP Commends the Launch of the National Peripheral Arterial Disease Awareness Campaign "Stay in Circulation: Take Steps to Learn About P.A.D." September 20, 2006.

THE SAGE GROUP Reports that the Acute Limb Ischemia (ALI) Market is Approximately $800 Million to $1.2 Billion. September 21, 2005.

Peripheral Arterial Disease (PAD)-Related Amputations Cost an Estimated $10 Billion, According to THE SAGE GROUP. September 9, 2004.

Peripheral Arterial Disease Represents a Significant and Rapidly Growing Market Opportunity for Interventional Therapies, Particularly Endovascular Technologies. August 25, 2004.

Peripheral Arterial Disease Seen as a Major New Market for Drug and Interventional Therapies, According to an Analysis Published by THE SAGE GROUP. May 21, 2003.

THE SAGE GROUP Research:

An estimated 2.8 million people in Western Europe have critical limb ischemia (CLI). Reflecting the ageing population, this number is projected to grow to 3.4 million by 2020.

Critical Limb Ischemia, Volume II Western Europe Epidemiology

In 2010 between 2.8 and 3.5 million U.S. citizens suffered from critical limb ischemia.

Critical Limb Ischemia
Volume I United States Epidemiology
(Revised)

Approximately 3 million people in India are currently afflicted with atherosclerotic critical limb ischemia.

India
Peripheral Arterial Disease, Thromboangiitis Obliterans & Critical Limb Ischemia
Epidemiology and Markets

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development